Connect with us

MyndYou Teams up with Mizuho Information & Research Institute to Detect Changes in Cognitive Function in Senior Adults in Japan

Avatar

Published

on

Reading Time: 2 minutes

The Digital Health company MyndYou recently secured its Seed round of
financing from Howard L. Morgan, Amplifyher Ventures, Female Founders
Fund, Impact 1st and more.

NEW YORK–(BUSINESS WIRE)–#AI–MyndYou and Mizuho Information & Research Institute (MHIR) have entered
into a partnership agreement to conduct a joint PoC in the Japanese
Market to improve quality of life and prolong independence of senior
adults. The companies aim to commercialize the service by the end of
FY2019.

MHIR will leverage MyndYou’s Artificial Intelligence (AI) platform,
which passively detects changes in cognitive function of individuals
through voice. The platform then delivers actionable insights to care
providers. MyndYou’s full solution allows for detection of changes in
cognitive function through passive tracking of voice and additional
parameters such as walking, driving and daily activities.

This partnership is announced on the heels of MyndYou’s Seed financing
round, led by Howard L. Morgan, with participation by Amplifyher
Ventures, Female Founders Fund and additional investors. MyndYou’s Seed
round brings its financing to-date to $2.1 Million.

The company entered the US market last year and is expanding services to
Physician Practices, ACOs, Home Health Companies and Rehabilitation
Companies.

“As a growing NY-based company with proprietary technology developed in
Tel Aviv, we have partnered with MHIR to further the global potential
for MyndYou,” says Ruth Polikaine, CEO of MyndYou. “Now, the senior
adult population in Japan will have access to a technology that can not
only reduce readmission rates, but also prolong their independence,
while providing them with personalized, data-driven remote care.”

“The number of dementia patients in Japan has reached 4.62 million and
is expected to increase even further to seven million, which equals to
one in five seniors over 65, in 2025. The disease has become an
important problem not only for the medical field but also for the entire
Japanese society※1. As in many cases, individuals with
dementia receive the diagnosis only after the symptoms have progressed.
Making a diagnosis and providing adequate care in the early stage is
necessary.” says Hitoshi Morio, Joint General Manager, Innovation &
Strategy Division, Mizuho Information & Research.
“However, the
number of opportunities to grasp changes in cognitive function in the
early stage has declined with the increase of single- person households
and the decrease of chances to interact with others. We see a big
opportunity to change that through the partnership with MyndYou.”

※1 ”White Paper on Aging Society/ 2016” by the
Cabinet of Japan

About MHIR
With IT as its core
technology, Mizuho Information & Research Institute, Inc. (MHIR) is a
professional organization with approximately 4,700 employees that
provides assistance to corporations in increasing their corporate value
through consulting, system integration and outsourcing services. Our
consulting services provide high-quality solutions to customers, with
experts in four distinct fields looking one step into the future:
socioeconomics, telecommunications, environmental energy and science.
MHIR
is one of core group companies of Mizuho Financial Group.

About MyndYou
The MyndYou artificial
intelligence (AI) platform was designed to revolutionize
cognitive-driven care. Through groundbreaking analytics of speech and
day-to-day activity patterns of older adults collected through remote
care sessions and a seamless monitoring app, MyndYou detects subtle
changes in cognitive functioning that activates care adjustments and
timely interventions. With passive and continuous monitoring, AI-driven
actionable insights, and seamless integration into today’s care methods,
MyndYou empowers clinicians to deliver personalized care that
revolutionizes patient engagement, reduces healthcare costs, and
improves quality of life.

Contacts

For inquiries, please contact:
Ruth Poliakine
CEO
MyndYou
ruth@myndyou.com

Cannabis

SLANG Worldwide to Participate in Investor Events

Newsfile

Published

on

Toronto, Ontario–(Newsfile Corp. – August 7, 2020) – SLANG Worldwide Inc. (CSE: SLNG), (“SLANG” or the “Company“), a leading global cannabis consumer packaged goods (CPG) company with a diversified portfolio of popular brands, today announced its participation in upcoming investor conferences.

August 12: Canaccord Genuity 40th Annual Growth Conference

SLANG CEO Chris Driessen will present at 10:00am EDT and be available for investor meetings, along with other members of the executive team.

August 18: Benzinga Virtual Cannabis Capital Conference

SLANG CEO Chris Driessen will participate in a fireside chat at 1:05pm EDT titled “Adaptability in Business – When and Where to Apply Capital or Pull it Back.”

Mr. Driessen has also joined the Benzinga Cannabis Advisory Council, comprised of thought leaders from different segments in the industry who come together to share their knowledge, connections and expertise with the Benzinga community.

The Company will post details of these and other events on its website, including links to any available webcasts, when they become available. Investors who wish to receive SLANG news releases, monthly newsletters and other information are encouraged to subscribe to the Company’s investor email list though its website.

Media and Investor inquiries

Investors@SLANGww.com

About SLANG Worldwide Inc.

SLANG Worldwide Inc. is a global leader in the cannabis CPG sector with a diversified portfolio of popular brands distributed across the United States. The Company specializes in acquiring and developing market-proven regional brands as well as launching innovative new brands to seize global market opportunities. SLANG is listed on the Canadian Securities Exchange under the ticker symbol SLNG. For more information, please visit www.slangww.com.

Forward-Looking Statements

This news release contains statements that constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management of SLANG at this time, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that could cause actual results to differ materially from those expressed or implied in such statements. Investors are cautioned not to put undue reliance on forward-looking statements. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to the COVID-19 global pandemic, changes in laws, resolutions and guidelines, market risks, concentration risks, operating history, competition, the risks associated with international and foreign operations and the other risks identified under the headings “Risk Factors” in SLANG’s final long form prospectus dated January 17, 2019 and “Risks and Uncertainties” in the management discussion and analysis for the year ended December 31, 2019 and three months ended March 31, 2020, each as filed on SEDAR at www.sedar.com. SLANG is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/61312

Continue Reading

Cannabis

PAOG CEO Interview: Cannabis Pharmaceutical Development; Acquired Revenue; Updated Financials; Why PPS Is Undervalued and Timing of Anticipated Correction

Newsfile

Published

on

Sandusky, Ohio–(Newsfile Corp. – August 7, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon. The interview is available on the MoneyTV website discussing new cannabis pharmaceutical developments, a recently acquired revenue stream, upcoming financial reports bringing the company current with OTC Markets and discussing why the current price per share (PPS) of PAOG is undervalued and what event is anticipated to correct the valuation . Mr. DiPrima also appeared on MoneyTV last week following PAOG’s acquisition of two medical cannabis companies.

PAOG New Logo

Cannot view this image? Visit: https://i0.wp.com/grassnews.net/wp-content/uploads/2020/08/paog-ceo-interview-cannabis-pharmaceutical-development-acquired-revenue-updated-financials-why-pps-is-undervalued-and-timing-of-anticipated-correction.jpg?w=740&ssl=1

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6729/61293_b28e543a14f6a95e_001full.jpg

Interview Highlights:

Mr. DiPrima discusses PAOG’s partnership with a Contract Research Organization (CRO) and a formal agreement in the works to advance an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for RespRx (one of the two acquisitions executed by PAOG last week) as a COPD treatment.

Based on positive results from an informal trial of RexpRx with 25 COVID-19 patients, PAOG also plans to make Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.

The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled, “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”

Mr. DiPrima confirms a recently published new PAOG website and the coming publication of PAOG’s financial reports. He further confirms the company now has a revenue base with the acquisition of a cannabis cultivation operation from Puration, Inc. (PURA). Mr. DiPrima concludes the interview with a discussion of why he believes the PPS is undervalued and that he anticipates a PPS correction when the PAOG financials are published.

MoneyTV with Donald Baillargeon is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.

The MoneyTV Interview is available at www.moneytv.net and will be syndicated across multiple channels and platforms.

www.paogroupinc.com

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION

Contact Us:
Jim DiPrima
888-272-6472
info@pao.group

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/61293

Continue Reading

Cannabis

PURA Announces Dividend Declaration Date and Anticipated Date of Record

Newsfile

Published

on

Dallas, Texas–(Newsfile Corp. – August 7, 2020) – Puration, Inc. (OTC Pink: PURA) today announced plans for a formal declaration of a dividend distribution this coming Monday, August 10, 2020. The dividend declaration is expected to be announced the following day, on Tuesday, August 11, 2020. The plan is for the dividend distribution date of record, or the day on which a shareholder must own stock to be eligible for the dividend to promptly follow the declaration date. The declaration date is subject to regulatory approval and the specific date will be released accordingly. The plan is also to pay the dividend promptly. The payment execution is subject to the payment process which involves the transfer agent(s) for the distributed stock and the broker network.

The planned dividend distribution to PURA shareholders results from the recent sale of PURA’s cannabis cultivation operation to PAO Group, Inc. (OTC Pink: PAOG).

The cannabis cultivation operation was sold last week in exchange for PAOG common stock. The stock is slated to be distributed to PURA shareholders in a dividend distribution. The planned distribution ratio is 1 for 1. Accordingly, PURA shareholders will receive one share of PAOG stock in exchange for every PURA share held.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/61295

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania